NCT03120208

Brief Summary

The objective of this cross-sectional study is to assess the prevalence of depression at 2 months, 6 months, and 1 year postpartum in women who had an immediate postpartum hemorrhage (immediate PPH defined as blood loss ≥ 500 mL within 24 hours of delivery). The potential serious consequences of PPH may lead to a greater number of psychological disorders in these women than in women without PPH.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,968

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 19, 2017

Completed
8 days until next milestone

Study Start

First participant enrolled

April 27, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

December 31, 2018

Status Verified

December 1, 2018

Enrollment Period

2.3 years

First QC Date

April 7, 2017

Last Update Submit

December 27, 2018

Conditions

Keywords

Postpartum psychological disordersimmediate postpartum hemorrhage.

Outcome Measures

Primary Outcomes (1)

  • prevalence of depression

    the prevalence of depression, measured by the Edinburgh postnatal depression scale (EPDS), validated in French, with a discrimination threshold ≥ 11

    at 12 months after delivery.

Secondary Outcomes (10)

  • prevalence of depression among women with PPH between 500-1000 mL compared with those with severe PPH (≥ 1000 mL)

    at 2 months, 6 months, and 12 months after delivery.

  • The prevalence of depression among women with a PPH requiring a so-called second-order medical intervention (transfusion, vascular embolization, etc.) compared with women who had a PPH without such a second-order intervention

    at 2 months, 6 months, and 12 months after delivery

  • severity of depression among women with PPH between 500-1000 mL compared with those with severe PPH (≥ 1000 mL)

    at 2 months, 6 months, and 12 months after delivery

  • severity of depression among women with a PPH requiring a so-called second-order medical intervention (transfusion, vascular embolization, etc.) compared with women who had a PPH without such a second-order intervention

    at 2 months, 6 months, and 12 months after delivery

  • prevalence of anxiety and post-traumatic stress among women after an immediate PPH

    at 2 months, 6 months, and 12 months after delivery

  • +5 more secondary outcomes

Study Arms (3)

women in the nonexposed group without a hemorrhage

EXPERIMENTAL
Behavioral: • The Edinburgh postnatal depression scale (EPDS), validated in French, with a discrimination threshold ≥ 11.Behavioral: The GAD-7 with a discrimination threshold ≥10.Behavioral: • Spielberger's State-Trait anxiety inventory, Form Y (validated in French), with a STAI (form Y-A) discrimination threshold ≥ 46Behavioral: The IES-R, validated in French, with a discrimination threshold ≥ 30.

women in the exposed group with a hemorrhage

EXPERIMENTAL
Behavioral: • The Edinburgh postnatal depression scale (EPDS), validated in French, with a discrimination threshold ≥ 11.Behavioral: The GAD-7 with a discrimination threshold ≥10.Behavioral: • Spielberger's State-Trait anxiety inventory, Form Y (validated in French), with a STAI (form Y-A) discrimination threshold ≥ 46Behavioral: The IES-R, validated in French, with a discrimination threshold ≥ 30.

Partners

EXPERIMENTAL
Behavioral: EPDS, MINI, STAI-A and B, IES-R and QEVA (experience)

Interventions

The Edinburgh postnatal depression scale (EPDS), validated in French, with a discrimination threshold ≥ 11.

women in the exposed group with a hemorrhagewomen in the nonexposed group without a hemorrhage

The GAD-7 with a discrimination threshold ≥10.

women in the exposed group with a hemorrhagewomen in the nonexposed group without a hemorrhage

Spielberger's State-Trait anxiety inventory, Form Y (validated in French), with a STAI (form Y-A) discrimination threshold ≥ 46

women in the exposed group with a hemorrhagewomen in the nonexposed group without a hemorrhage

The IES-R, validated in French, with a discrimination threshold ≥ 30.

women in the exposed group with a hemorrhagewomen in the nonexposed group without a hemorrhage

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women who gave birth at a term ≥ 22 weeks' gestation or, if the term is unknown, to a fetus with a birth weight ≥ 500 g),
  • regardless of the type of delivery (vaginal or cesarean),
  • regardless of parity or fetal presentation,
  • and regardless of type of pregnancy (singleton or multiple).
  • and affiliated with French CNAMTS (salaried worker) health insurance.

You may not qualify if:

  • Women who are:
  • minors,
  • who do not understand French,
  • who refuse to participate (did not sign consent),
  • and who did not give birth at the Clermont-Ferrand University Hospital Center maternity unit and were secondarily transferred there postpartum.
  • For the partners:
  • Partner of a woman who gave birth at a term ≥ 22 weeks of gestation or, if the term is unknown, to a fetus with a birth weight ≥ 500 g),
  • Regardless of the type of delivery (vaginal or cesarean),
  • Regardless of parity and fetal presentation,
  • And regardless of type of pregnancy (singleton or multiple),
  • And both partners are affiliated with French CNAMTS (salaried worker) health insurance.
  • Partner of a woman who gave birth at a term \< 22 weeks of gestation or, if the term is unknown, to a fetus with a birth weight \< 500 g),
  • Partner who does not understand French,
  • Who refuses to participate (does not sign consent),
  • Partner who is a minor,
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

RECRUITING

Related Publications (1)

  • Pranal M, Legrand A, de Chazeron I, Llorca PM, Vendittelli F. Prevalence of maternal psychological disorders after immediate postpartum haemorrhage: a repeated cross-sectional study - the PSYCHE* study protoco. BMJ Open. 2019 Sep 4;9(9):e027390. doi: 10.1136/bmjopen-2018-027390.

MeSH Terms

Conditions

Postpartum HemorrhageDepression, Postpartum

Interventions

Psychiatric Status Rating Scales

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPuerperal DisordersUterine HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsDepressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Neuropsychological TestsPsychological TestsBehavioral Disciplines and Activities

Study Officials

  • Marine PRANAL JULIEN

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
open
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2017

First Posted

April 19, 2017

Study Start

April 27, 2017

Primary Completion

August 1, 2019

Study Completion

February 1, 2020

Last Updated

December 31, 2018

Record last verified: 2018-12

Locations